BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 15464038)

  • 21. Tristetraprolin regulates the expression of the human inducible nitric-oxide synthase gene.
    Fechir M; Linker K; Pautz A; Hubrich T; Förstermann U; Rodriguez-Pascual F; Kleinert H
    Mol Pharmacol; 2005 Jun; 67(6):2148-61. PubMed ID: 15778452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions.
    Tiscornia AC; Cayota A; Landoni AI; Brito C; Oppezzo P; Vuillier F; Robello C; Dighiero G; Gabús R; Pritsch O
    Leukemia; 2004 Jan; 18(1):48-56. PubMed ID: 14574328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression profile of a human inducible nitric oxide synthase promoter reporter in transgenic mice during endotoxemia.
    Yu Z; Xia X; Kone BC
    Am J Physiol Renal Physiol; 2005 Jan; 288(1):F214-20. PubMed ID: 15507544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors.
    Kolodziejski PJ; Koo JS; Eissa NT
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18141-6. PubMed ID: 15601772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. iNOS-mediated nitric oxide production and its regulation.
    Aktan F
    Life Sci; 2004 Jun; 75(6):639-53. PubMed ID: 15172174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin.
    Lechner M; Lirk P; Rieder J
    Semin Cancer Biol; 2005 Aug; 15(4):277-89. PubMed ID: 15914026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells.
    Eizirik DL; Flodström M; Karlsen AE; Welsh N
    Diabetologia; 1996 Aug; 39(8):875-90. PubMed ID: 8858209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine regulation of inducible nitric oxide synthase in vascular smooth muscle cells.
    Cohen J; Evans TJ; Spink J
    Prog Clin Biol Res; 1998; 397():169-77. PubMed ID: 9575557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte nuclear factor-4alpha mediates redox sensitivity of inducible nitric-oxide synthase gene transcription.
    Guo H; Cai CQ; Kuo PC
    J Biol Chem; 2002 Feb; 277(7):5054-60. PubMed ID: 11741883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and functions of inducible nitric oxide synthase].
    Tsutsui M; Ueno S; Toyohira Y; Yanagihara N
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():460-4. PubMed ID: 15506427
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene.
    Taylor BS; Geller DA
    Shock; 2000 Jun; 13(6):413-24. PubMed ID: 10847627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA and human inducible nitric oxide synthase.
    Guo Z; Geller DA
    Vitam Horm; 2014; 96():19-27. PubMed ID: 25189382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage recruitment follows the pattern of inducible nitric oxide synthase expression in a model for carpal tunnel syndrome.
    Gupta R; Lin YM; Bui P; Chao T; Preston C; Mozaffar T
    J Neurotrauma; 2003 Jul; 20(7):671-80. PubMed ID: 12908928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional activation of the human inducible nitric-oxide synthase promoter by Kruppel-like factor 6.
    Warke VG; Nambiar MP; Krishnan S; Tenbrock K; Geller DA; Koritschoner NP; Atkins JL; Farber DL; Tsokos GC
    J Biol Chem; 2003 Apr; 278(17):14812-9. PubMed ID: 12590140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
    Hecker M; Cattaruzza M; Wagner AH
    Gen Pharmacol; 1999 Jan; 32(1):9-16. PubMed ID: 9888247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis.
    Hersberger M; Bonhoeffer S; Rampini SK; Opravil M; Marti-Jaun J; Telenti A; Hänseler E; Ledergerber B; Speck RF;
    Clin Exp Immunol; 2004 Sep; 137(3):566-9. PubMed ID: 15320907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide synthase: expression and expressional control of the three isoforms.
    Förstermann U; Kleinert H
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):351-64. PubMed ID: 8532063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cysteine-Zn2+ complexes: unique molecular switches for inducible nitric oxide synthase-derived NO.
    Kröncke KD
    FASEB J; 2001 Nov; 15(13):2503-7. PubMed ID: 11689476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus.
    Kuhn A; Fehsel K; Lehmann P; Krutmann J; Ruzicka T; Kolb-Bachofen V
    J Invest Dermatol; 1998 Jul; 111(1):149-53. PubMed ID: 9665402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of promoter-dependent transcriptional activity of inducible nitric oxide synthase by sodium butyrate in colon cancer cells.
    Sasahara Y; Mutoh M; Takahashi M; Fukuda K; Tanaka N; Sugimura T; Wakabayashi K
    Cancer Lett; 2002 Mar; 177(2):155-61. PubMed ID: 11825662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.